Show simple item record

dc.contributor.authorUygunoglu, Ugur
dc.contributor.authorSaip, Sabahattin
dc.contributor.authorDurasi, Ilknur Melis
dc.contributor.authorDemirci, Nuri Onat
dc.contributor.authorTutuncu, Melih
dc.contributor.authorAvsar, Timucin
dc.contributor.authorSEZERMAN, Osman Uğur
dc.contributor.authorSiva, Aksel
dc.contributor.authorTuranli, Eda Tahir
dc.date.accessioned2021-03-02T22:43:36Z
dc.date.available2021-03-02T22:43:36Z
dc.date.issued2015
dc.identifier.citationAvsar T., Durasi I. M. , Uygunoglu U., Tutuncu M., Demirci N. O. , Saip S., SEZERMAN O. U. , Siva A., Turanli E. T. , "CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical Subtypes.", PloS one, cilt.10, sa.5, 2015
dc.identifier.issn1932-6203
dc.identifier.otherav_0e537e9e-8157-4e3e-8915-b30679ffb202
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/15209
dc.identifier.urihttps://doi.org/10.1371/journal.pone.0122045
dc.description.abstractMultiple sclerosis (MS) is an immune-mediated, neuro-inflammatory, demyelinating and neurodegenerative disease of the central nervous system (CNS) with a heterogeneous clinical presentation and course. There is a remarkable phenotypic heterogeneity in MS, and the molecular mechanisms underlying it remain unknown. We aimed to investigate further the etiopathogenesis related molecular pathways in subclinical types of MS using proteomic and bioinformatics approaches in cerebrospinal fluids of patients with clinically isolated syndrome, relapsing remitting MS and progressive MS (n=179). Comparison of disease groups with controls revealed a total of 151 proteins that are differentially expressed in clinically different MS subtypes. KEGG analysis using PANOGA tool revealed the disease related pathways including aldosterone-regulated sodium reabsorption (p=8.02x10(-5)) which is important in the immune cell migration, renin-angiotensin (p=6.88x10(-5)) system that induces Th17 dependent immunity, notch signaling (p=1.83x10(-10)) pathway indicating the activated remyelination and vitamin digestion and absorption pathways (p=1.73x10(-5)). An emerging theme from our studies is that whilst all MS clinical forms share common biological pathways, there are also clinical subtypes specific and pathophysiology related pathways which may have further therapeutic implications.
dc.language.isoeng
dc.subjectTemel Bilimler
dc.subjectÇOK DİSİPLİNLİ BİLİMLER
dc.subjectDoğa Bilimleri Genel
dc.subjectTemel Bilimler (SCI)
dc.titleCSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical Subtypes.
dc.typeMakale
dc.relation.journalPloS one
dc.contributor.departmentİstanbul Teknik Üniversitesi , ,
dc.identifier.volume10
dc.identifier.issue5
dc.contributor.firstauthorID30448


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record